PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $60,912,000 | +250.1% | 1,600,000 | +300.0% | 2.54% | +322.8% |
| Q2 2019 | $17,396,000 | +14.3% | 400,000 | 0.0% | 0.60% | -8.7% |
| Q1 2019 | $15,224,000 | -11.5% | 400,000 | 0.0% | 0.66% | -36.1% |
| Q4 2018 | $17,208,000 | -15.3% | 400,000 | -3.2% | 1.03% | +10.3% |
| Q3 2018 | $20,309,000 | -56.6% | 413,196 | -71.7% | 0.93% | -48.2% |
| Q2 2018 | $46,813,000 | -12.4% | 1,460,610 | -14.8% | 1.80% | -29.4% |
| Q1 2018 | $53,424,000 | +37.9% | 1,715,072 | +102.1% | 2.55% | +1.6% |
| Q4 2017 | $38,737,000 | -21.3% | 848,572 | -35.3% | 2.51% | -34.3% |
| Q3 2017 | $49,245,000 | +121.6% | 1,311,460 | +181.5% | 3.82% | +36.1% |
| Q2 2017 | $22,220,000 | +18.8% | 465,818 | +13.6% | 2.81% | +17.5% |
| Q1 2017 | $18,696,000 | – | 410,000 | – | 2.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |